These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

901 related items for PubMed ID: 17066423

  • 1. Cancer/testis antigen expression and specific cytotoxic T lymphocyte responses in non small cell lung cancer.
    Groeper C, Gambazzi F, Zajac P, Bubendorf L, Adamina M, Rosenthal R, Zerkowski HR, Heberer M, Spagnoli GC.
    Int J Cancer; 2007 Jan 15; 120(2):337-43. PubMed ID: 17066423
    [Abstract] [Full Text] [Related]

  • 2. Expression of the MAGE-A4 and NY-ESO-1 cancer-testis antigens and T cell infiltration in non-small cell lung carcinoma and their prognostic significance.
    Yoshida N, Abe H, Ohkuri T, Wakita D, Sato M, Noguchi D, Miyamoto M, Morikawa T, Kondo S, Ikeda H, Nishimura T.
    Int J Oncol; 2006 May 15; 28(5):1089-98. PubMed ID: 16596224
    [Abstract] [Full Text] [Related]

  • 3. Generation of CTL recognizing an HLA-A*0201-restricted epitope shared by MAGE-A1, -A2, -A3, -A4, -A6, -A10, and -A12 tumor antigens: implication in a broad-spectrum tumor immunotherapy.
    Graff-Dubois S, Faure O, Gross DA, Alves P, Scardino A, Chouaib S, Lemonnier FA, Kosmatopoulos K.
    J Immunol; 2002 Jul 01; 169(1):575-80. PubMed ID: 12077290
    [Abstract] [Full Text] [Related]

  • 4. Detection of naturally processed and HLA-A1-presented melanoma T-cell epitopes defined by CD8(+) T-cells' release of granulocyte-macrophage colony-stimulating factor but not by cytolysis.
    Maeurer MJ, Martin D, Elder E, Storkus WJ, Lotze MT.
    Clin Cancer Res; 1996 Jan 01; 2(1):87-95. PubMed ID: 9816095
    [Abstract] [Full Text] [Related]

  • 5. Expression of cancer-testis antigens MAGE-A3/6 and NY-ESO-1 in non-small-cell lung carcinomas and their relationship with immune cell infiltration.
    Kim SH, Lee S, Lee CH, Lee MK, Kim YD, Shin DH, Choi KU, Kim JY, Park DY, Sol MY.
    Lung; 2009 Jan 01; 187(6):401-11. PubMed ID: 19795170
    [Abstract] [Full Text] [Related]

  • 6. Clinical significance of immunohistochemical expression of cancer/testis tumor-associated antigens (MAGE-A1, MAGE-A3/4, NY-ESO-1) in patients with non-small cell lung cancer.
    Grah JJ, Katalinic D, Juretic A, Santek F, Samarzija M.
    Tumori; 2014 Jan 01; 100(1):60-8. PubMed ID: 24675493
    [Abstract] [Full Text] [Related]

  • 7. Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes.
    Jäger E, Chen YT, Drijfhout JW, Karbach J, Ringhoffer M, Jäger D, Arand M, Wada H, Noguchi Y, Stockert E, Old LJ, Knuth A.
    J Exp Med; 1998 Jan 19; 187(2):265-70. PubMed ID: 9432985
    [Abstract] [Full Text] [Related]

  • 8. Immunohystochemical expression of cancer/testis antigens (MAGE-A3/4, NY-ESO-1) in non-small cell lung cancer: the relationship with clinical-pathological features.
    Grah J, Samija M, Juretić A, Sarcević B, Sobat H.
    Coll Antropol; 2008 Sep 19; 32(3):731-6. PubMed ID: 18982744
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Identification of new melanoma epitopes on melanosomal proteins recognized by tumor infiltrating T lymphocytes restricted by HLA-A1, -A2, and -A3 alleles.
    Kawakami Y, Robbins PF, Wang X, Tupesis JP, Parkhurst MR, Kang X, Sakaguchi K, Appella E, Rosenberg SA.
    J Immunol; 1998 Dec 15; 161(12):6985-92. PubMed ID: 9862734
    [Abstract] [Full Text] [Related]

  • 11. Combined use of oligonucleotide and tissue microarrays identifies cancer/testis antigens as biomarkers in lung carcinoma.
    Sugita M, Geraci M, Gao B, Powell RL, Hirsch FR, Johnson G, Lapadat R, Gabrielson E, Bremnes R, Bunn PA, Franklin WA.
    Cancer Res; 2002 Jul 15; 62(14):3971-9. PubMed ID: 12124329
    [Abstract] [Full Text] [Related]

  • 12. Calreticulin acts as an adjuvant to promote dendritic cell maturation and enhances antigen-specific cytotoxic T lymphocyte responses against non-small cell lung cancer cells.
    Liu X, Li J, Liu Y, Ding J, Tong Z, Liu Y, Zhou Y, Liu Y.
    Cell Immunol; 2016 Feb 15; 300():46-53. PubMed ID: 26702740
    [Abstract] [Full Text] [Related]

  • 13. Identification of five MAGE-A1 epitopes recognized by cytolytic T lymphocytes obtained by in vitro stimulation with dendritic cells transduced with MAGE-A1.
    Chaux P, Luiten R, Demotte N, Vantomme V, Stroobant V, Traversari C, Russo V, Schultz E, Cornelis GR, Boon T, van der Bruggen P.
    J Immunol; 1999 Sep 01; 163(5):2928-36. PubMed ID: 10453041
    [Abstract] [Full Text] [Related]

  • 14. Peptide-specific CTL in tumor infiltrating lymphocytes from metastatic melanomas expressing MART-1/Melan-A, gp100 and Tyrosinase genes: a study in an unselected group of HLA-A2.1-positive patients.
    Spagnoli GC, Schaefer C, Willimann TE, Kocher T, Amoroso A, Juretic A, Zuber M, Luscher U, Harder F, Heberer M.
    Int J Cancer; 1995 Oct 20; 64(5):309-15. PubMed ID: 7591302
    [Abstract] [Full Text] [Related]

  • 15. Clinical significance of cancer/testis antigens expression in patients with non-small cell lung cancer.
    Shigematsu Y, Hanagiri T, Shiota H, Kuroda K, Baba T, Mizukami M, So T, Ichiki Y, Yasuda M, So T, Takenoyama M, Yasumoto K.
    Lung Cancer; 2010 Apr 20; 68(1):105-10. PubMed ID: 19545928
    [Abstract] [Full Text] [Related]

  • 16. Clinical significance of expression of cancer/testis antigen and down-regulation of HLA class-I in patients with stage I non-small cell lung cancer.
    Hanagiri T, Shigematsu Y, Shinohara S, Takenaka M, Oka S, Chikaishi Y, Nagata Y, Baba T, Uramoto H, So T, Yamada S.
    Anticancer Res; 2013 May 20; 33(5):2123-8. PubMed ID: 23645764
    [Abstract] [Full Text] [Related]

  • 17. Predictive and prognostic effect of CD133 and cancer-testis antigens in stage Ib-IIIA non-small cell lung cancer.
    Su C, Xu Y, Li X, Ren S, Zhao C, Hou L, Ye Z, Zhou C.
    Int J Clin Exp Pathol; 2015 May 20; 8(5):5509-18. PubMed ID: 26191258
    [Abstract] [Full Text] [Related]

  • 18. Identification of five new HLA-B*3501-restricted epitopes derived from common melanoma-associated antigens, spontaneously recognized by tumor-infiltrating lymphocytes.
    Benlalam H, Linard B, Guilloux Y, Moreau-Aubry A, Derré L, Diez E, Dreno B, Jotereau F, Labarrière N.
    J Immunol; 2003 Dec 01; 171(11):6283-9. PubMed ID: 14634146
    [Abstract] [Full Text] [Related]

  • 19. Generation of specific anti-melanoma reactivity by stimulation of human tumor-infiltrating lymphocytes with MAGE-1 synthetic peptide.
    Salgaller ML, Weber JS, Koenig S, Yannelli JR, Rosenberg SA.
    Cancer Immunol Immunother; 1994 Aug 01; 39(2):105-16. PubMed ID: 7519125
    [Abstract] [Full Text] [Related]

  • 20. Expansion of cancer germline antigen-specific cytotoxic T lymphocytes for immunotherapy.
    Krishnadas DK, Wang Y, Sundaram K, Bai F, Lucas KG.
    Tumour Biol; 2017 Jul 01; 39(7):1010428317701309. PubMed ID: 28677424
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 46.